Table 5 Association between baseline factors and changes in T1/ECV
T1 SAX Mid Gradient (ms per Year) | T1 SAX Mid ECV Gradient (pp per Year) | |||||
|---|---|---|---|---|---|---|
N | Mean ± SD | p-Value | N | Mean ± SD | p-Value | |
Age at First Scan* | 26 | −0.137* | 0.505* | 24 | 0.169 | 0.430 |
Ethnicity | 0.278 | 0.360 | ||||
White British | 18 | 26.3 ± 25.2 | 17 | 1.8 ± 2.5 | ||
Other | 8 | 12.7 ± 35.9 | 7 | 0.7 ± 2.6 | ||
Gender | 0.112 | 0.864 | ||||
Male | 17 | 15.5 ± 29.4 | 15 | 1.4 ± 2.5 | ||
Female | 9 | 34.5 ± 24.8 | 9 | 1.6 ± 2.8 | ||
ACE/ARB | 0.969 | 0.771 | ||||
No | 6 | 21.7 ± 56.6 | 5 | 1.8 ± 2.9 | ||
Yes | 20 | 22.2 ± 16.0 | 19 | 1.4 ± 2.5 | ||
Statins/Fibrates | 0.103 | 0.121 | ||||
No | 14 | 30.7 ± 22.5 | 14 | 2.1 ± 2.8 | ||
Yes | 12 | 12.1 ± 33.1 | 10 | 0.5 ± 1.7 | ||
Hypertension | 0.930 | 0.117 | ||||
No | 11 | 21.5 ± 35.6 | 10 | 0.5 ± 2.4 | ||
Yes | 15 | 22.5 ± 24.2 | 14 | 2.1 ± 2.4 | ||
Hyperlipidaemia | 0.040 | 0.989 | ||||
No | 11 | 35.5 ± 21.8 | 11 | 1.5 ± 2.2 | ||
Yes | 15 | 12.3 ± 30.1 | 13 | 1.5 ± 2.8 | ||
Infantile cardiomyopathy | 0.710 | 0.904 | ||||
No | 16 | 20.4 ± 33.0 | 15 | 1.5 ± 2.9 | ||
Yes | 10 | 24.9 ± 22.0 | 9 | 1.4 ± 1.9 | ||
Diabetes | 0.764 | 0.132 | ||||
No | 9 | 19.7 ± 39.3 | 9 | 0.5 ± 2.5 | ||
Yes | 17 | 23.4 ± 23.0 | 15 | 2.1 ± 2.4 | ||
Insulin resistance (not diabetes) | 0.752 | 0.870 | ||||
No | 20 | 21.1 ± 30.2 | 18 | 1.5 ± 2.6 | ||
Yes | 6 | 25.5 ± 26.3 | 6 | 1.3 ± 2.4 | ||
CKD | 0.889 | 0.630 | ||||
No | 12 | 23.0 ± 33.3 | 12 | 1.2 ± 2.0 | ||
Yes | 14 | 21.4 ± 25.8 | 12 | 1.7 ± 3.0 | ||
Presence of CAD** | 0.622 | 0.121 | ||||
No | 20 | 23.5 ± 27.5 | 20 | 1.0 ± 2.0 | ||
Yes | 3 | 32.7 ± 44.7 | 3 | 3.4 ± 4.7 | ||